Skip to main content


Showing posts with the label Subjective Perspectives

Subjective Perspectives

Subjective Perspectives This domain consists of multiple elements, ranging from well-being and quality of life to preference of medications to awareness of the illness. Representative rating scales would include the subjective well-being under neuroleptics: SWN40 (short version of 20 items), drug attitude inventory: DAI41 (short version of 10 items), MOS 36-item short-form health survey: SF-3642 or its shorter 12-item version: SF-12,43 the WHO Quality of Life-BREF: WHOQOL-BREF44 (26 items), and the Scale to Assess Unawareness of Mental Disorder: SUMD45 (20 items), although they have not been commonly utilized (only in <10% of the studies). In practice, it is possible that patients with substantial symptoms and impairments may regard their lives as ‘good’.46 In contrast, a report indicating that psychosocial functioning was negatively associated with self-esteem and satisfaction with life47 might not argue against the possibility that patients with relatively higher functioning could

Subjective Perspectives

Subjective Perspectives While some of the studies recorded this domain with the usage of the rating scales, only the quality of life scale: QLS18 (21 items) has been used in 12% of the 2009 studies.